Hematology NewsASCO honors Hagop Kantarjian, MD, for leukemia researchMay 16, 2023CMLALLAMLBusiness of MedicineMixed TopicsMyelodysplastic Syndrome
Hematology NewsRed-cell donor’s sex does not affect transfusion survivalApril 18, 2023TransplantBleeding DisordersMyelodysplastic Syndrome
Hematology NewsVEXAS syndrome: More common, variable, and severe than expectedJanuary 24, 2023Rare DiseasesMyelodysplastic SyndromeAnemia
Hematology NewsBias and other barriers to HSCT accessSeptember 1, 2022Multiple MyelomaTransplantMixed TopicsAMLMyelodysplastic Syndrome
Hematology News‘Superior’ CLL regimen cuts chemo in halfJune 28, 2022CLLCellular TherapyMixed TopicsGene TherapyMyelodysplastic SyndromeAML
Hematology News‘Extremely exciting’ study results guide MM treatment optionsJune 6, 2022Multiple MyelomaTransplantAMLMyelodysplastic SyndromeMixed Topics
Hematology NewsPrecision medicine: A new approach to AML, other blood cancersDecember 12, 2021AMLMyelodysplastic Syndrome
Hematology NewsMyeloid patients respond robustly to Moderna COVID vaccineDecember 12, 2021COVID-19 UpdatesAMLMyelodysplastic Syndrome
Hematology NewsFor leukemias, COVID-19 death risks tied to poor prognoses, ICU deferralsDecember 11, 2021ALLCOVID-19 UpdatesMyelodysplastic SyndromeAML
Hematology NewsGenotype, need for transfusion predict death in VEXAS syndromeNovember 9, 2021Rare DiseasesMyelodysplastic Syndrome
MDS: Elevated mature monocytes in bone marrow can supplement IPSS-R as a prognostic indicatorJune 8, 2021Myelodysplastic Syndrome
MDS: Antibiotics can be stopped after 3 days in patients with febrile neutropenia after chemotherapyJune 8, 2021Myelodysplastic Syndrome
De novo MDS: Pretransplant RBC and platelet transfusion burden tied to poor survival outcomesJune 8, 2021Myelodysplastic Syndrome
